Literature DB >> 22641137

Crystal arthritis: Canakinumab relieves gout flares when treatment options are limited.

Sarah Onuora.   

Abstract

Entities:  

Year:  2012        PMID： 22641137     DOI： 10.1038/nrrheum.2012.90

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.

Authors:  Naomi Schlesinger; Rieke E Alten; Thomas Bardin; H Ralph Schumacher; Mark Bloch; Alberto Gimona; Gerhard Krammer; Valda Murphy; Dominik Richard; Alexander K So
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103
  1 in total
  1 in total

1.  Gout: a critical analysis of scientific development.

Authors:  Alexander Gerber; David A Groneberg; Doris Klingelhöfer; Matthias Bundschuh
Journal:  Rheumatol Int       Date:  2013-06-25       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.